UNSPSC 51343804: Emtricitabine/tenofovir

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM800. This VA Drug Class (AM800) classifies this compound as belonging to the group ANTIVIRALS.

UNSPSC 51343804 Emtricitabine/tenofovir is a Commodity code that nominally covers antiretroviral pharmaceutical products, yet the recent state and local opportunities tagged under this code show little alignment with that scope. The Illinois Department of Public Health and Seminole County, Florida have posted procurements classified under this code, but their actual buys—doxycycline, ciprofloxacin, naloxone, and drug deactivation systems—fall outside the emtricitabine/tenofovir product family and suggest a mismatch between code assignment and procurement reality. Issuing bodies using this code include state health departments and county community health programs, typically sourcing through piggyback cooperative purchasing vehicles or competitive invitation-for-bid processes.

Recent activity is geographically sparse and consists of a completed award rather than an open opportunity. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (solicitation 26482DPHPREPDB53392), though this is a closed award notification, not an active solicitation. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though the response deadline listed (July 26, 2023) predates the posting date and likely reflects a data entry error. The code shows minimal recent solicitation activity, and the opportunities that do appear under it involve products substantially different from the code's stated scope, suggesting either systematic miscoding or that this commodity is being sourced through broader pharmaceutical frameworks rather than targeted RFPs.